[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]
RE: Re: Source of cancer data
John Williams wrote:
<<. . . the NCI funds a few states to track incidence data. . . .>>
But not all, and as was pointed out previously, how could a sample of the
population be more accurate than the entire population?
Jack Earley
Radiological Engineer
-----Original Message-----
From: John Williams [mailto:JohnWi@law.com]
Sent: Tuesday, December 18, 2001 10:38 PM
To: radsafe
Subject: Re: Re: Source of cancer data
The incidence data reflects new cancers that arise that year. The
mortality data reflect people who have died that year.
The SEER data http://seer.cancer.gov/ is better because the NCI
funds a few states to track incidence data with a high degree of
confidence. They have abstractors out in the field looking at
pathology reports etc. Many states have cancer registries, but the
data is not as good generally because they rely on death certificates
and one does not know that what they died from was or was not their
orginal cancer. The SEER database goes one step further and tries to
identify the original cancer. For example, someone can have an
initial lung cancer, but show as a cause of death heart failure
because the cancer ate throught the aorta.
That is why Smith et al found a good bit of difference between their
SEER data and Cohen's data from his atlas.
The SEER Registries serve as the source information to track changes
in cancers nationwide.
John WIlliams
Sent by Law Mail
************************************************************************
You are currently subscribed to the Radsafe mailing list. To unsubscribe,
send an e-mail to Majordomo@list.vanderbilt.edu Put the text "unsubscribe
radsafe" (no quote marks) in the body of the e-mail, with no subject line.
************************************************************************
You are currently subscribed to the Radsafe mailing list. To unsubscribe,
send an e-mail to Majordomo@list.vanderbilt.edu Put the text "unsubscribe
radsafe" (no quote marks) in the body of the e-mail, with no subject line.